Rowatinex meke želučanootporne kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

rowatinex meke želučanootporne kapsule

rowa pharmaceuticals ltd., newtown, bantry, co. cork, irska - &alpha pinen ß pinen kamfen cineol fenhon anetol borneol - želučanootporna kapsula, meka - 24,8 mg + 6,2 mg + 15 mg + 3 mg + 4 mg + 4 mg + 10 mg - urbroj: svaka kapsula sadrži: α-pinen 24,8 mg, β-pinen 6,2 mg, kamfena 15 mg, cineola 3 mg, fenhona 4 mg, anetola 4 mg i borneola 10 mg

ROWATINEX 24,8 mg/1 kapsula+ 6,2 mg/1 kapsula+ < 15 mg/1 kapsula+ 3 mg/1 kapsula+ 4 mg/1 kapsula+ 10 mg/1 kapsula+ 4 mg/1 kap Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

rowatinex 24,8 mg/1 kapsula+ 6,2 mg/1 kapsula+ < 15 mg/1 kapsula+ 3 mg/1 kapsula+ 4 mg/1 kapsula+ 10 mg/1 kapsula+ 4 mg/1 kap

medical intertrade d.o.o. sarajevo - alfa-pinen, anetol, beta-pinen, борнеол, cineol, fenhon, kamfen - želučanootporna kapsula, meka - 24,8 mg/1 kapsula+ 6,2 mg/1 kapsula+ < 15 mg/1 kapsula+ 3 mg/1 kapsula+ 4 mg/1 kapsula+ 10 mg/1 kapsula+ 4 mg/1 kapsula - 1 želučanootporna kapsula, meka sadrži: 24,8 mg alfa pinen, 6,2 mg beta pinen, 15 mg kamfen, 3 mg cineol, 4 mg fenhon, 10 mg borneol, 4 mg anetol

Zepatier Europska Unija - hrvatski - EMA (European Medicines Agency)

zepatier

merck sharp & dohme b.v. - danas tvrtka otvara, razvija, grazoprevir - hepatitis c, kronični - direct acting antivirals, antivirals for systemic use, antivirals for treatment of hcv infections - zepatier is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients 12 years of age and older who weigh at least 30 kg (see sections 4. 2, 4. 4 i 5. virus hepatitisa c (hcv) genotip-specifične aktivnosti vidi 4. 4 i 5.

Epclusa Europska Unija - hrvatski - EMA (European Medicines Agency)

epclusa

gilead sciences ireland uc - Софосбувир, velpatasvir - hepatitis c, kronični - antivirusni lijekovi za sustavnu uporabu - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 i 5.

Sovaldi Europska Unija - hrvatski - EMA (European Medicines Agency)

sovaldi

gilead sciences ireland uc - Софосбувир - hepatitis c, kronični - antivirusni lijekovi za sustavnu uporabu - sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 i 5. virus hepatitisa c (hcv) genotip određene aktivnosti, vidi 4. 4 i 5. sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adults and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 i 5. virus hepatitisa c (hcv) genotip određene aktivnosti, vidi 4. 4 i 5.

Maviret Europska Unija - hrvatski - EMA (European Medicines Agency)

maviret

abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - hepatitis c, kronični - antivirusni lijekovi za sustavnu uporabu - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.

Vosevi Europska Unija - hrvatski - EMA (European Medicines Agency)

vosevi

gilead sciences ireland uc - Софосбувир, velpatasvir, voxilaprevi - hepatitis c, kronični - antivirusni lijekovi za sustavnu uporabu - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (vidi 4. 2, 4. 4 i 5.

Harvoni Europska Unija - hrvatski - EMA (European Medicines Agency)

harvoni

gilead sciences ireland uc - ледипасвир, софосбувир - hepatitis c, kronični - antivirusni lijekovi za sustavnu uporabu - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 i 5. virus hepatitisa c (hcv) genotip-specifične aktivnosti vidi 4. 4 i 5.

Juluca Europska Unija - hrvatski - EMA (European Medicines Agency)

juluca

viiv healthcare b.v. - долутегравир natrija, рилпивирин hidroklorid - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - juluca indiciran za liječenje virusa humane imunodeficijencije tipa 1 (hiv-1) infekcije kod odraslih, koji вирусологически.-potisnuta (hiv-1 rna.

Vocabria Europska Unija - hrvatski - EMA (European Medicines Agency)

vocabria

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.